Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
CALL
Canadian Natural Resources
CNQ
$94.9B
| $424K | ﹤0.01% |
49,621
-79,842
| -62% | -$645K |
|
3427
German American Bancorp
GABC
$1.9B
| $424K | ﹤0.01% |
13,643
+5,405
| +66% | +$156K |
|
3428
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $423K | ﹤0.01% |
16,592
+10,367
| +167% | +$217K |
|
|
SNP
3429
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $423K | ﹤0.01% |
10,085
-6,014
| -37% | -$284K |
|
3430
Koppers
KOP
$985M
| $422K | ﹤0.01% |
22,470
+3,727
| +20% | +$56.6K |
|
3431
nLIGHT
LASR
$3.17B
| $422K | ﹤0.01% |
18,979
+8,000
| +73% | +$152K |
|
3432
REX American Resources
REX
$1.41B
| $422K | ﹤0.01% |
36,552
-25,722
| -41% | -$255K |
|
3433
Customers Bancorp
CUBI
$2.77B
| $421K | ﹤0.01% |
35,009
+5,237
| +18% | +$58.4K |
|
3434
PUT
DXC Technology
DXC
$1.73B
| $421K | ﹤0.01% |
25,500
-26,500
| -51% | -$421K |
|
3435
Red Rock Resorts
RRR
$3.62B
| $421K | ﹤0.01% |
38,650
+8,581
| +29% | +$97K |
|
3436
BancFirst
BANF
$3.8B
| $420K | ﹤0.01% |
10,370
+4,179
| +68% | +$153K |
|
3437
First Bancorp
FBNC
$2.68B
| $419K | ﹤0.01% |
16,710
+6,926
| +71% | +$167K |
|
3438
Genesco
GCO
$422M
| $418K | ﹤0.01% |
19,319
-11,634
| -38% | -$215K |
|
3439
Nexstar Media Group
NXST
$5.92B
| $418K | ﹤0.01% |
4,981
-178,002
| -97% | -$13.4M |
|
3440
PUT
ProShares Ultra Silver
AGQ
$1.36B
| $416K | ﹤0.01% |
14,200
-11,600
| -45% | -$285K |
|
3441
PUT
Canadian National Railway
CNI
$76.6B
| $416K | ﹤0.01% |
4,700
-1,300
| -22% | -$108K |
|
|
EB
3442
DELISTED
Eventbrite
EB
| $415K | ﹤0.01% |
48,322
+28,480
| +144% | +$251K |
|
3443
CALL
Henry Schein
HSIC
$9.82B
| $415K | ﹤0.01% |
7,100
-8,200
| -54% | -$458K |
|
|
CBAY
3444
DELISTED
Cymabay Therapeutics
CBAY
| $415K | ﹤0.01% |
118,801
-19,218
| -14% | -$55.5K |
|
|
CCF
3445
DELISTED
Chase Corporation
CCF
| $415K | ﹤0.01% |
4,052
+1,617
| +66% | +$151K |
|
|
ODT
3446
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $415K | ﹤0.01% |
9,813
+4,000
| +69% | +$129K |
|
|
DESP
3447
DELISTED
Despegar.com
DESP
| $414K | ﹤0.01% |
57,700
+43,500
| +306% | +$302K |
|
3448
Genpact
G
$5.81B
| $413K | ﹤0.01% |
11,300
-5,990
| -35% | -$202K |
|
3449
Harmonic Inc
HLIT
$1.28B
| $413K | ﹤0.01% |
86,929
+9,873
| +13% | +$55.2K |
|
|
BHR
3450
Braemar Hotels & Resorts
BHR
$142M
| $412K | ﹤0.01% |
144,251
+112,912
| +360% | +$328K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.